Biotech Day In Review: Genentech, Inc. Beats Estimates Slightly

After the closing bell, Genentech (DNA) reported an earnings increase of 68% over the year-earlier first quarter. The company made a profit of $421 million or 39 cents per share on revenue of $2.84 billion, a 43% jump.’>>> Discuss This Story

MORE ON THIS TOPIC